Keyword Analysis & Research: suvorexant


Keyword Analysis


Keyword Research: People who searched suvorexant also searched

Frequently Asked Questions

Is Suvorexant a Dora?

Suvorexant (Belsomra; Merck & Co., Inc., Whitehouse Station, NJ, USA) is the first dual orexin receptor antagonist (DORA) to be approved for the treatment of insomnia. Suvorexant improves both sleep latency and sleep maintenance in patients with insomnia [Merck & Co., Inc., 2013].

What is suvorexant used for?

Suvorexant is used treat insomnia (difficulty falling asleep or staying asleep). Suvorexant is in a class of medications called orexin receptor antagonists. It works by blocking the action of a certain natural substance in the brain that causes wakefulness.

Is suvorexant effective for the treatment of primary insomnia?

Suvorexant is a dual orexin receptor agonist and is currently approved for the treatment of insomnia in the United States and Japan. We conducted a systematic review and meta-analysis to assess the efficacy and safety of suvorexant for the treatment of primary insomnia. We searched PubMed, EMBASE, a …

Is suvorexant an effective orexin receptor antagonist?

Suvorexant is an effective orexin receptor antagonist with a unique clinical profile. Evidence suggests that this medication offers a sustained benefit for patients with symptoms of chronic insomnia. REFERENCES 1. Dopp J, Phillips B. Sleep disorders.


Search Results related to suvorexant on Search Engine